M. Expression-de-ki-67, A) Méningiome méningothélial de grade I (HES, x200) (B) Méningiome atypique (grade II), avec nécrose tumorale (x400) (C) Rares cellules marquées avec l'anticorps MIB1 (Ki-67) dans un méningiome de grade I (x400). (D) Expression modérée de Ki-67 dans un méningiome atypique (x400). (E) Expression faible de MCM6 (x400) dans un méningiome de grade I

G. Perry, A. Louis, D. Scheithauer, and B. , Effets de miR16 et miR519 sur la prolifération : résultats préliminaires Bibliographie 1, WHO Classification of tumours of the Central Nervous System, pp.164-172

W. Mason, F. Gentili, and D. Macdonald, Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningiomas, Journal of Neurosurgery, vol.37, issue.2, pp.341-346, 2002.
DOI : 10.1016/S0360-3016(98)90008-6

B. Ragel and R. Jensen, New Approaches for the Treatment of Refractory Meningiomas, Cancer Control, vol.97, issue.5, pp.148-158, 2003.
DOI : 10.3171/jns.2002.97.2.0441

J. Chun, M. Mcdermott, and K. Lamborn, Delayed surgical resection reduces intraoperative blood loss for embolized meningiomas, Neurosurgery, vol.50, pp.1231-1235, 2002.

A. Borg, J. Ekanayake, and R. Mair, Preoperative particle and glue embolization of meningiomas: indications, results, and lessons learned from 117 consecutive patients, Neurosurgery, vol.73, issue.252, pp.244-251, 2013.

A. Shah, N. Patel, and D. Raper, The role of preoperative embolization for intracranial meningiomas, Journal of Neurosurgery, vol.27, issue.1, pp.364-372, 2013.
DOI : 10.1177/15910199980040S111

A. Singla, E. Deshaies, and V. Melnyk, Controversies in the role of preoperative embolization in meningioma management, Neurosurgical Focus, vol.14, issue.6, p.17, 2013.
DOI : 10.1227/NEU.0b013e3181fe2de9

V. Barresi, G. Branca, and F. Granata, Embolized meningiomas: risk of overgrading and neo-angiogenesis, Journal of Neuro-Oncology, vol.208, issue.3, pp.207-219, 2013.
DOI : 10.1007/s11060-010-0312-8

R. Jensen, S. Soleau, and M. Bhayani, Expression of hypoxia inducible factor???1 alpha and correlation with preoperative embolization of meningiomas, Journal of Neurosurgery, vol.59, issue.3, pp.658-667, 2002.
DOI : 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W

Z. Shi, L. Feng, and X. Jiang, Therapeutic embolization of meningiomas with Onyx for delayed surgical resection, Surgical Neurology, vol.70, issue.5, pp.478-481, 2008.
DOI : 10.1016/j.surneu.2007.05.031

M. Bendszus, I. Martin-schrader, and H. Schlake, Embolisation of intracranial meningiomas without subsequent surgery, Neuroradiology, vol.45, issue.7, pp.451-455, 2003.
DOI : 10.1007/s00234-003-1005-1

J. Willis, C. Smith, and J. Ironside, The accuracy of meningioma grading: a 10-year retrospective audit, Neuropathology and Applied Neurobiology, vol.23, issue.2, pp.141-149, 2005.
DOI : 10.1053/hupa.2001.27119

A. Terzi, E. Saglam, and A. Barak, The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays, Pathology - Research and Practice, vol.204, issue.5, pp.305-314, 2008.
DOI : 10.1016/j.prp.2008.01.013

O. Ozen, B. Demirhan, and N. Altinors, Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas, Clin Neuropathol, vol.24, pp.219-224, 2005.

S. Lanzafame, A. Torrisi, and G. Barbagallo, Correlation between Histological Grade, MIB-1, p53, and Recurrence in 69 Completely Resected Primary Intracranial Meningiomas with a 6 Year Mean Follow-up, Pathology - Research and Practice, vol.196, issue.7, pp.483-488, 2000.
DOI : 10.1016/S0344-0338(00)80050-3

E. Karamitopoulou, E. Perentes, and M. Tolnay, Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas, Human Pathology, vol.29, issue.2, pp.140-145, 1998.
DOI : 10.1016/S0046-8177(98)90224-6

V. Amatya, Y. Takeshima, and K. Sugiyama, Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas, Human Pathology, vol.32, issue.9, pp.970-975, 2001.
DOI : 10.1053/hupa.2001.27119

D. Hunt, A. Freeman, and L. Morris, Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein, British Journal of Neurosurgery, vol.16, issue.1, pp.10-15, 2002.
DOI : 10.1080/02688690120114174

M. Moller and O. Braendstrup, No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry, Journal of Neuro-Oncology, vol.34, issue.3, pp.241-246, 1997.
DOI : 10.1023/A:1005794700267

M. Cobb, M. Husain, and B. Andersen, Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma, Journal of Neurosurgery, vol.9, issue.1, pp.85-90, 1996.
DOI : 10.1128/MCB.9.1.57

A. Alama, F. Barbieri, and R. Spaziante, Significance of cyclin D1 expression in meningiomas: A preliminary study, Journal of Clinical Neuroscience, vol.14, issue.4, pp.355-358, 2007.
DOI : 10.1016/j.jocn.2006.04.001

K. Labib, J. Tercero, and J. Diffley, Uninterrupted MCM2-7 Function Required for DNA Replication Fork Progression, Science, vol.288, issue.5471, pp.1643-1647, 2000.
DOI : 10.1126/science.288.5471.1643

A. Facoetti, E. Ranza, and E. Benericetti, Minichromosome maintenance protein 7: a reliable tool for glioblastoma proliferation index, Anticancer Res, vol.26, pp.1071-1075, 2006.

A. Facoetti, E. Ranza, and I. Grecchi, Immunohistochemical evaluation of minichromosome maintenance protein 7 in astrocytoma grading, Anticancer Res, vol.26, pp.3513-3516, 2006.

S. Wharton, K. Chan, and J. Anderson, Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis, Neuropathology and Applied Neurobiology, vol.50, issue.4, pp.305-313, 2001.
DOI : 10.1136/jnnp.50.3.304

O. Saydam, O. Senol, and T. Schaaij-visser, Comparative Protein Profiling Reveals Minichromosome Maintenance (MCM) Proteins As Novel Potential Tumor Markers for Meningiomas, Journal of Proteome Research, vol.9, issue.1
DOI : 10.1021/pr900834h

C. Lee, R. Johnson, and J. Wichterman-kouznetsova, High-throughput screening for genes that prevent excess DNA replication in human cells and for molecules that inhibit them, Methods, vol.57, issue.2, pp.234-248, 2012.
DOI : 10.1016/j.ymeth.2012.03.031

W. Ma and H. Furneaux, Localization of the human HuR gene to chromosome 19p13.2, Human Genetics, vol.99, issue.1, pp.32-33, 1997.
DOI : 10.1007/s004390050305

P. Kundu, M. Fabian, and N. Sonenberg, HuR protein attenuates miRNA-mediated repression by promoting miRISC dissociation from the target RNA, Nucleic Acids Research, vol.13, issue.11, pp.5088-5100, 2012.
DOI : 10.1261/rna.646007

K. Abdelmohsen, M. Gorospe, C. Brennan, and J. Steitz, Posttranscriptional regulation of cancer traits by HuR HuR and mRNA stability, Wiley Interdiscip Rev RNA. Cellular and molecular life sciences : CMLS, vol.158, issue.33, pp.214-229266, 2001.

M. Hinman and H. Lou, Diverse molecular functions of Hu proteins. Cellular and molecular life sciences : CMLS, pp.3168-3181, 2008.

I. Lopez-de-silanes, A. Lal, and M. Gorospe, HuR: Post-Transcriptional Paths to Malignancy, RNA Biology, vol.2, issue.1, pp.11-13, 2005.
DOI : 10.4161/rna.2.1.1552

S. Lebedeva, J. M. Theil, and K. , Transcriptome-wide Analysis of Regulatory Interactions of the RNA-Binding Protein HuR, Molecular Cell, vol.43, issue.3, pp.340-352, 2011.
DOI : 10.1016/j.molcel.2011.06.008

N. Mukherjee, D. Corcoran, and J. Nusbaum, Integrative Regulatory Mapping Indicates that the RNA-Binding Protein HuR Couples Pre-mRNA Processing and mRNA Stability, Molecular Cell, vol.43, issue.3, pp.327-339, 2011.
DOI : 10.1016/j.molcel.2011.06.007

K. Abdelmohsen, S. Srikantan, and X. Yang, Ubiquitin-mediated proteolysis of HuR by heat shock, The EMBO Journal, vol.172, issue.9, pp.1271-1282, 2009.
DOI : 10.1016/0168-9525(90)90183-7

K. Abdelmohsen, M. Kim, and S. Srikantan, miR-519 suppresses tumor growth by reducing HuR levels, Cell Cycle, vol.9, issue.7, pp.1354-1359, 2010.
DOI : 10.4161/cc.9.7.11164

H. Li, S. Park, and B. Kilburn, Lipopolysaccharide-induced Methylation of HuR, an mRNA-stabilizing Protein, by CARM1, Journal of Biological Chemistry, vol.13, issue.47, pp.44623-44630, 2002.
DOI : 10.1128/MCB.20.13.4765-4772.2000

F. Xu, X. Zhang, and Y. Lei, Loss of Repression of HuR Translation by miR-16 May Be Responsible for the Elevation of HuR in Human Breast Carcinoma, Journal of Cellular Biochemistry, vol.38, issue.5, pp.727-734, 2010.
DOI : 10.1172/JCI12973

N. Filippova, X. Yang, and Y. Wang, The RNA-Binding Protein HuR Promotes Glioma Growth and Treatment Resistance, Molecular Cancer Research, vol.9, issue.5, pp.648-659, 2011.
DOI : 10.1158/1541-7786.MCR-10-0325

T. Williams, C. Costantino, and N. Bildzukewicz, ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells, PLoS One. Br J Cancer, vol.5100, pp.32-15455, 2009.

G. Botta, D. Santis, L. Saladino, and R. , Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins, Current Medicinal Chemistry, vol.19, issue.34, pp.5871-5884, 2012.
DOI : 10.2174/092986712804143303

Y. Qu, J. Zhang, and S. Wu, SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines, Neuroscience Letters, vol.525, issue.2, pp.168-172, 2012.
DOI : 10.1016/j.neulet.2012.07.025

F. Nurwidya, F. Takahashi, and K. Minakata, From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers, Anatomy & Cell Biology, vol.45, issue.2, pp.73-78, 2012.
DOI : 10.5115/acb.2012.45.2.73

P. Yoo, C. Sullivan, and S. Kiang, Tissue Microarray Analysis of 560 Patients with Colorectal Adenocarcinoma: High Expression of HuR Predicts Poor Survival, Annals of Surgical Oncology, vol.66, issue.16, pp.200-207, 2009.
DOI : 10.1158/0008-5472.CAN-05-4362

M. Heinonen, P. Bono, and K. Narko, Cytoplasmic HuR Expression Is a Prognostic Factor in Invasive Ductal Breast Carcinoma, Cancer Research, vol.65, issue.6, pp.2157-2161, 2005.
DOI : 10.1158/0008-5472.CAN-04-3765

C. Denkert, W. Weichert, and S. Pest, Overexpression of the Embryonic-Lethal Abnormal Vision-like Protein HuR in Ovarian Carcinoma Is a Prognostic Factor and Is Associated with Increased Cyclooxygenase 2 Expression, Cancer Research, vol.64, issue.1, pp.189-195, 2004.
DOI : 10.1158/0008-5472.CAN-03-1987

C. Denkert, W. Weichert, and K. Winzer, Expression of the ELAV-Like Protein HuR Is Associated with Higher Tumor Grade and Increased Cyclooxygenase-2 Expression in Human Breast Carcinoma, Clinical Cancer Research, vol.10, issue.16, pp.5580-5586, 2004.
DOI : 10.1158/1078-0432.CCR-04-0070

D. Stoppoloni, I. Cardillo, and A. Verdina, Expression of the embryonic lethal abnormal vision-like protein HuR in human mesothelioma, Cancer, vol.352, issue.10, pp.2761-2769, 2008.
DOI : 10.4161/rna.2.1.1552

J. Wang, W. Zhao, and Y. Guo, The Expression of RNA-Binding Protein HuR in Non-Small Cell Lung Cancer Correlates with Vascular Endothelial Growth Factor-C Expression and Lymph Node Metastasis, Oncology, vol.76, issue.6, pp.420-429, 2009.
DOI : 10.1159/000216837

J. Wang, B. Wang, and J. Bi, Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human astrocytic tumors, Neuropathology, vol.28, pp.604-611, 2008.

L. Nabors, G. Gillespie, and L. Harkins, HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine-and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs, Cancer Res, vol.61, pp.2154-2161, 2001.

F. Bolognani, A. Gallani, and L. Sokol, mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells, Journal of Neuro-Oncology, vol.3, issue.1, pp.531-542, 2011.
DOI : 10.1371/journal.pmed.0030006

T. Sakuma, T. Nakagawa, and K. Ido, Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE, J Neurooncol. Proc Natl Acad Sci U S A, vol.88106, issue.59, pp.143-15521930, 2008.

L. Pons, S. Battaglia-hsu, and C. Orozco-barrios, Anchoring Secreted Proteins in Endoplasmic Reticulum by Plant Oleosin: The Example of Vitamin B12 Cellular Sequestration by Transcobalamin, PLoS ONE, vol.4, issue.7
DOI : 10.1371/journal.pone.0006325.g006

URL : https://hal.archives-ouvertes.fr/hal-00559010

M. Kang, B. Ryu, and M. Lee, NF-kappaB activates transcription of the RNA-binding factor

. Hur, AKT signaling, to promote gastric tumorigenesis, Gastroenterology, vol.135, pp.2030-2042, 2008.

J. Yi, N. Chang, and X. Liu, Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence, Nucleic Acids Research, vol.175, issue.11, pp.1547-1558, 2010.
DOI : 10.1083/jcb.200607020

R. Mazroui, D. Marco, S. Clair, and E. , Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis, The Journal of Cell Biology, vol.115, issue.1, pp.113-127, 2008.
DOI : 10.1016/S0092-8674(00)80501-2

K. Abdelmohsen, S. Srikantan, and Y. Kuwano, miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels, Proceedings of the National Academy of Sciences, vol.3, issue.3, pp.20297-20302, 2008.
DOI : 10.1371/journal.pone.0001864

W. Lee, K. Shibata, M. Inagaki, and K. Ajiro, Characterization of a newly established malignant meningioma cell line of the human brain, Neurosurgery, vol.27192, issue.66, pp.389-39587, 1990.
DOI : 10.1097/00006123-199009000-00008

M. Hendzel, Y. Wei, and M. Mancini, Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation, Chromosoma, vol.106, issue.6, pp.348-360, 1997.
DOI : 10.1007/s004120050256

C. Tapia, H. Kutzner, and T. Mentzel, Two Mitosis-Specific Antibodies, MPM-2 and Phospho-Histone H3 (Ser28), Allow Rapid and Precise Determination of Mitotic Activity, The American Journal of Surgical Pathology, vol.30, issue.1, pp.83-89, 2006.
DOI : 10.1097/01.pas.0000183572.94140.43

T. Ribalta, I. Mccutcheon, and K. Aldape, The Mitosis-Specific Antibody Anti-Phosphohistone-H3 (PHH3) Facilitates Rapid Reliable Grading of Meningiomas According to WHO 2000 Criteria, The American Journal of Surgical Pathology, vol.28, issue.11, pp.1532-1536, 2004.
DOI : 10.1097/01.pas.0000141389.06925.d5

J. Gerdes, L. Li, and C. Schlueter, Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67, Am J Pathol, vol.138, pp.867-873, 1991.

M. Mengel, R. Von-wasielewski, and B. Wiese, Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial, The Journal of Pathology, vol.106, issue.3, pp.292-299, 2002.
DOI : 10.1093/ajcp/106.5.634

P. Mckeever, M. Strawderman, and B. Yamini, MIB-1 proliferation index predicts survival among patients with grade II astrocytoma Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia, J Neuropathol Exp Neurol. Br J Cancer, vol.5795, pp.931-936314, 1998.

I. Scott, L. Morris, and K. Bird, A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer, The Journal of Pathology, vol.54, issue.2, pp.187-197, 2003.
DOI : 10.1038/ncb813

S. Kingsbury, M. Loddo, and T. Fanshawe, Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells, Experimental Cell Research, vol.309, issue.1, pp.56-67, 2005.
DOI : 10.1016/j.yexcr.2005.05.027

K. Eward, E. Obermann, and S. Shreeram, DNA replication licensing in somatic and germ cells, Journal of Cell Science, vol.117, issue.24, pp.5875-5886, 2004.
DOI : 10.1242/jcs.01503

D. Aximu, A. Azad, and R. Ni, A Pilot Evaluation of a Novel Immunohistochemical Assay for Topoisomerase II-?? and Minichromosome Maintenance Protein 2 Expression (ProEx C) in Cervical Adenocarcinoma In Situ, Adenocarcinoma, and Benign Glandular Mimics, International Journal of Gynecological Pathology, vol.28, issue.2, pp.114-119, 2009.
DOI : 10.1097/PGP.0b013e3181895573

A. Boyd, B. Shakhtour, and Y. Shyr, Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases, Journal of the American Academy of Dermatology, vol.58, issue.5, pp.750-754, 2008.
DOI : 10.1016/j.jaad.2007.12.026

M. Gonzalez, S. Pinder, and G. Callagy, Minichromosome Maintenance Protein 2 Is a Strong Independent Prognostic Marker in Breast Cancer, Journal of Clinical Oncology, vol.21, issue.23, pp.4306-4313, 2003.
DOI : 10.1200/JCO.2003.04.121

A. Hanna-morris, S. Badvie, and P. Cohen, Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67, Journal of Clinical Pathology, vol.62, issue.4
DOI : 10.1136/jcp.2007.054643

A. Helfenstein, S. Frahm, and M. Krams, Minichromosome Maintenance Protein (MCM6) in Low-Grade Chondrosarcoma, American Journal of Clinical Pathology, vol.122, issue.6
DOI : 10.1309/G638TKNNG2CJUXWL

J. Kikuchi, I. Kinoshita, and Y. Shimizu, Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer, Lung Cancer, vol.72, issue.2, pp.229-237, 2011.
DOI : 10.1016/j.lungcan.2010.08.020

K. Lau, Q. Chan, and J. Pang, Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion, Oncogene, vol.19, issue.40
DOI : 10.1016/j.jmb.2004.05.024

P. Adams, Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1471, issue.3
DOI : 10.1016/S0304-419X(01)00019-1

K. Barton and E. Levine, Expression patterns and cell cycle profiles of PCNA, MCM6, cyclin D1, cyclin A2, cyclin B1, and phosphorylated histone H3 in the developing mouse retina, Developmental Dynamics, vol.68, issue.3, pp.672-682, 2008.
DOI : 10.1002/dvdy.21449

S. Jirawatnotai, Y. Hu, and W. Michowski, A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers, Nature, vol.463, issue.7350, pp.230-234, 2011.
DOI : 10.1038/nature08684

A. Gladden and J. Diehl, The Cyclin D1-dependent Kinase Associates with the Pre-replication Complex and Modulates RB??MCM7 Binding, Journal of Biological Chemistry, vol.131, issue.11, pp.9754-9760, 2003.
DOI : 10.1073/pnas.032677499

D. Lane and S. Benchimol, p53: oncogene or anti-oncogene?, Genes & Development, vol.4, issue.1, pp.1-8, 1990.
DOI : 10.1101/gad.4.1.1

V. Amatya, Y. Takeshima, and K. Inai, Methylation of p14 ARF gene in meningiomas and its correlation to the p53 expression and mutation, Modern Pathology, vol.38, issue.6, pp.705-710, 2004.
DOI : 10.1023/A:1005946001915

H. Cho, S. Ha, and S. Park, Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas, Journal of Korean Medical Science, vol.14, issue.2, pp.199-205, 1999.
DOI : 10.3346/jkms.1999.14.2.199

T. Joachim, Z. Ram, and Z. Rappaport, Comparative analysis of theNF2, TP53, PTEN, KRAS, NRAS andHRAS genes in sporadic and radiation-induced human meningiomas, International Journal of Cancer, vol.84, issue.2, pp.218-221, 2001.
DOI : 10.1002/(SICI)1097-0215(19990621)84:3<216::AID-IJC3>3.0.CO;2-E

J. Wang, Z. Zhang, and M. Hartman, Detection ofTP53 gene mutation in human meningiomas: A study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and dna sequencing techniques on paraffin-embedded samples, International Journal of Cancer, vol.216, issue.4, pp.223-228, 1995.
DOI : 10.1016/0014-2964(70)90069-1

T. Yakut, A. Bekar, and M. Doygun, Evaluation of relationship between chromosome 22 and p53 gene alterations and the subtype of meningiomas by the interphase-FISH technique, Teratogenesis, Carcinogenesis, and Mutagenesis, vol.29, issue.29, pp.217-225, 2002.
DOI : 10.1016/S0046-8177(98)90224-6

B. Chozick, D. Benzil, and E. Stopa, Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas, Journal of Neuro-Oncology, vol.27, issue.2, pp.117-126, 1996.
DOI : 10.1007/BF00177474

Y. Kamei, M. Watanabe, and T. Nakayama, Prognostic significance of p53 and p21WAF1/CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas, Journal of Neuro-Oncology, vol.46, issue.3, pp.205-213, 2000.
DOI : 10.1023/A:1006440430585

G. Nagashima, M. Aoyagi, and M. Yamamoto, P53 Overexpression and Proliferative Potential in Malignant Meningiomas, Acta Neurochirurgica, vol.141, issue.1, pp.53-61, 1999.
DOI : 10.1007/s007010050266

H. Lehr, D. Mankoff, and D. Corwin, Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer, Journal of Histochemistry & Cytochemistry, vol.3, issue.11, pp.1559-1565, 1997.
DOI : 10.1159/000217683

I. Lopez-de-silanes, J. Fan, and X. Yang, Role of the RNA-binding protein HuR in colon carcinogenesis, Oncogene, vol.22, issue.46, pp.7146-7154, 2003.
DOI : 10.1016/S0002-9440(10)64856-0

R. Ghemrawi, S. Pooya, and S. Lorentz, Decreased vitamin B12 availability induces ER stress through impaired SIRT1-deacetylation of HSF1, Cell Death & Disease, vol.15, issue.3, p.553, 2013.
DOI : 10.1128/MCB.15.8.4319

URL : https://hal.archives-ouvertes.fr/hal-01701059

W. Wang, C. Yan, and J. Zhang, SIRT1 inhibits TNF-??-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1, Apoptosis, vol.20, issue.6, pp.689-701, 2013.
DOI : 10.1089/scd.2010.0465

W. Yan, Z. Fang, and Q. Yang, Sirt1 Mediates Hyperbaric Oxygen Preconditioning-Induced Ischemic Tolerance in Rat Brain, Journal of Cerebral Blood Flow & Metabolism, vol.113, issue.3, pp.396-406, 2013.
DOI : 10.1038/nature01036

K. Matsuda, H. Takeuchi, and Y. Arai, Atypical and ischemic features of embolized meningiomas, Brain Tumor Pathology, vol.21, issue.1, pp.17-24, 2012.
DOI : 10.1097/00000478-199712000-00008

E. Patsouris, R. Laas, and C. Hagel, Increased proliferative activity due to necroses induced by pre-operative embolization in benign meningiomas, Journal of Neuro-Oncology, vol.40, issue.3, pp.257-264, 1998.
DOI : 10.1023/A:1006070220882

W. Paulus, J. Meixensberger, and E. Hofmann, Effect of embolisation of meningioma on Ki-67 proliferation index., Journal of Clinical Pathology, vol.46, issue.9, pp.876-877, 1993.
DOI : 10.1136/jcp.46.9.876

V. Gabai, L. Meng, and G. Kim, Heat Shock Transcription Factor Hsf1 Is Involved in Tumor Progression via Regulation of Hypoxia-Inducible Factor 1 and RNA-Binding Protein HuR, Molecular and Cellular Biology, vol.32, issue.5, pp.929-940, 2012.
DOI : 10.1128/MCB.05921-11

S. Lee, Y. Lee, and Y. Hong, Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas, APMIS, vol.108, issue.1, pp.16-24, 2014.
DOI : 10.1007/s00401-004-0875-6

R. Jensen and J. Lee, Predicting Outcomes of Patients With Intracranial Meningiomas Using Molecular Markers of Hypoxia, Vascularity, and Proliferation, Neurosurgery, vol.38, issue.4, pp.146-156, 2012.
DOI : 10.1016/j.humpath.2006.07.020

D. Gong, J. Zhang, and M. Yu, Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma, Clin Interv Aging, vol.8, pp.889-897, 2013.

S. Kuo, H. Lin, and S. Chien, SIRT1 suppresses breast cancer growth through downregulation of the Bcl-2 protein, Oncology Reports, vol.30, issue.1, pp.125-130, 2013.
DOI : 10.3892/or.2013.2470

J. Lee, S. Bae, and J. Jeong, Hypoxia-inducible factor (HIF-1)??: its protein stability and biological functions, Experimental & Molecular Medicine, vol.36, issue.1, pp.1-12, 2004.
DOI : 10.1038/emm.2004.1

A. Kaya, N. Gunel, and M. Benekli, Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients, J Buon, vol.17, pp.663-668, 2012.

M. Lopez, C. Esteban, E. Berros, and J. , Prognostic Factors in Patients With Advanced Renal Cell Carcinoma, Clinical Genitourinary Cancer, vol.10, issue.4, pp.262-270, 2012.
DOI : 10.1016/j.clgc.2012.06.005

M. Volm and R. Koomagi, Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer, Anticancer Res, vol.20, pp.1527-1533, 2000.

W. Jeong, A. Rapisarda, and S. Park, Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1alpha), in patients with refractory solid tumors

K. Kim, H. Jung, and H. Kwon, A new anti-angiogenic small molecule, G0811, inhibits angiogenesis via targeting hypoxia inducible factor (HIF)-1?? signal transduction, Biochemical and Biophysical Research Communications, vol.441, issue.2, pp.399-404, 2013.
DOI : 10.1016/j.bbrc.2013.10.075

E. Gothie, D. Richard, and E. Berra, Identification of Alternative Spliced Variants of Human Hypoxia-inducible Factor-1??, Journal of Biological Chemistry, vol.2, issue.10, pp.6922-6927, 2000.
DOI : 10.1093/emboj/18.7.1905

K. Lee, J. Park, and Y. Chun, Non-hypoxic transcriptional activation of the aryl hydrocarbon receptor nuclear translocator in concert with a novel hypoxia-inducible factor-1alpha isoform, Nucleic Acids Research, vol.32, issue.18, pp.5499-5511, 2004.
DOI : 10.1093/nar/gkh880

D. Lukashev, C. Caldwell, and A. Ohta, Differential Regulation of Two Alternatively Spliced Isoforms of Hypoxia-inducible Factor-1?? in Activated T Lymphocytes, Journal of Biological Chemistry, vol.63, issue.52, pp.48754-48763, 2001.
DOI : 10.1038/sj.onc.1204193

D. Lukashev and M. Sitkovsky, Preferential expression of the novel alternative isoform I.3 of hypoxia-inducible factor 1?? in activated human T lymphocytes, Human Immunology, vol.69, issue.7, pp.421-425, 2008.
DOI : 10.1016/j.humimm.2008.05.004

C. Vigouroux, Dérégulation de HuR (ELAV-like 1) et prolifération dans les carcinomes bronchiques non à petites cellules. Faculté de Médecine, 2013.

M. Vazquez-chantada, D. Fernandez-ramos, and N. Embade, HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation

T. Fujiwara, Y. Mori, and D. Chu, CARM1 regulates proliferation of PC12 cells by methylating HuD. Molecular and cellular biology, pp.2273-2285, 2006.

A. Doller, S. Huwiler, and A. , Posttranslational Modification of the AU-Rich Element Binding Protein HuR by Protein Kinase C?? Elicits Angiotensin II-Induced Stabilization and Nuclear Export of Cyclooxygenase 2 mRNA, Molecular and Cellular Biology, vol.28, issue.8, pp.2608-2625, 2008.
DOI : 10.1128/MCB.01530-07

A. Doller, K. Schlepckow, and H. Schwalbe, Tandem Phosphorylation of Serines 221 and 318 by Protein Kinase C?? Coordinates mRNA Binding and Nucleocytoplasmic Shuttling of HuR, Molecular and Cellular Biology, vol.30, issue.6, pp.1397-1410, 2010.
DOI : 10.1128/MCB.01373-09

A. Doller, A. Huwiler, and R. Muller, Protein Kinase C??-dependent Phosphorylation of the mRNA-stabilizing Factor HuR: Implications for Posttranscriptional Regulation of Cyclooxygenase-2, Molecular Biology of the Cell, vol.18, issue.6, pp.2137-2148, 2007.
DOI : 10.1091/mbc.E06-09-0850

A. Doller, C. Winkler, and I. Azrilian, High-constitutive HuR phosphorylation at Ser 318 by PKC?? propagates tumor relevant functions in colon carcinoma cells, Carcinogenesis, vol.1470, issue.5, pp.676-685, 2011.
DOI : 10.1002/ijc.21373

K. Abdelmohsen, R. Pullmann, J. Lal, and A. , Phosphorylation of HuR by Chk2 Regulates SIRT1 Expression, Molecular Cell, vol.25, issue.4, pp.543-557, 2007.
DOI : 10.1016/j.molcel.2007.01.011

H. Kim, K. Abdelmohsen, and A. Lal, Nuclear HuR accumulation through phosphorylation by Cdk1, Genes & Development, vol.22, issue.13, pp.1804-1815, 2008.
DOI : 10.1101/gad.1645808

S. Srikantan, K. Tominaga, and M. Gorospe, Functional Interplay between RNA-Binding Protein HuR and microRNAs, Current Protein & Peptide Science, vol.13, issue.4, pp.372-379, 2012.
DOI : 10.2174/138920312801619394

F. Xu, X. Zhang, and Y. Lei, Loss of Repression of HuR Translation by miR-16 May Be Responsible for the Elevation of HuR in Human Breast Carcinoma, Journal of Cellular Biochemistry, vol.38, issue.5, pp.727-734
DOI : 10.1172/JCI12973

L. Young, A. Moore, and L. Sokol, The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Molecular cancer research : MCR, pp.167-180, 2012.

T. Yang, X. Luo, and T. Wu, miR-16 inhibits glioma cell growth and invasion through the suppression of BCL2 and NF-kappaB1/MMP-9 signaling pathway. Cancer science, 2014.

M. Van-kouwenhove, M. Kedde, and R. Agami, MicroRNA regulation by RNA-binding proteins and its implications for cancer, Nature Reviews Cancer, vol.16, issue.9, pp.644-656, 2011.
DOI : 10.1261/rna.2091710

W. Al-ahmadi, M. Al-ghamdi, and N. Souhibani, miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer, The Journal of Pathology, vol.55, issue.1, pp.28-38, 2013.
DOI : 10.4161/adna.18739

X. Guo, Y. Wu, and R. Hartley, MicroRNA-125a represses cell growth by targeting HuR in breast cancer, RNA Biology, vol.6, issue.5, pp.575-583, 2009.
DOI : 10.4161/rna.6.5.10079

M. Epis, A. Barker, and K. Giles, Gene Expression by MicroRNA miR-331-3p in Prostate Cancer Cells, Journal of Biological Chemistry, vol.7, issue.48, pp.41442-41454, 2011.
DOI : 10.1261/rna.768207

H. Kim, Y. Kuwano, and S. Srikantan, HuR recruits let-7/RISC to repress c-Myc expression, Genes & Development, vol.23, issue.15
DOI : 10.1101/gad.1812509

N. Chang, J. Yi, and G. Guo, HuR Uses AUF1 as a Cofactor To Promote p16INK4 mRNA Decay, Molecular and Cellular Biology, vol.30, issue.15, pp.3875-3886, 2010.
DOI : 10.1128/MCB.00169-10

M. Machouart, Primary cerebral alveolar echinococcosis: mycology to the rescue, J Clin Microbiol, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01483915

A. Chapelet, G. Audibert, F. Plénat, J. Vignaud, and G. Gauchotte, [A sudden cardiac arrest during the anesthesia induction]. Ann Pathol, p.24331728, 2013.

J. Guéant and F. Namour, CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features, Biochimie. Feb, vol.97, pp.210-218, 2013.

P. Trechot, J. Jouzeau, C. Brouillard, J. Scala-bertola, N. Petitpain et al., Role of nicotinic acid and nicotinamide in nicorandil-induced ulcerations: from hypothesis to demonstration, International Wound Journal, vol.10, issue.Suppl. 3, p.24028540, 2013.
DOI : 10.1111/j.1742-481X.2012.00966.x

URL : https://hal.archives-ouvertes.fr/hal-01464818

D. Nguyen, G. Gauchotte, P. Nguyen-thi, and R. Jankowski, Does surgery of the olfactory clefts modify the sense of smell?, American Journal of Rhinology & Allergy, vol.27, issue.4, pp.317-338, 2013.
DOI : 10.2500/ajra.2013.27.3907

URL : https://hal.archives-ouvertes.fr/hal-01701239

A. Bressenot, J. Chevaux, N. Williet, A. Oussalah, A. Germain et al., Submucosal Plexitis as a Predictor of Postoperative Surgical Recurrence in Crohn??s Disease, Inflammatory Bowel Diseases, vol.19, issue.8, pp.1654-61
DOI : 10.1097/MIB.0b013e318281f336

G. Gauchotte, M. Wissler, J. Casse, J. Pujo, C. Minetti et al., FVIIIra, CD15, and tryptase performance in the diagnosis of skin stab wound vitality in forensic pathology, International Journal of Legal Medicine, vol.191, issue.1???3, pp.957-65, 2013.
DOI : 10.1016/j.forsciint.2009.05.020

G. Gauchotte, S. Lacomme, L. Brochin, B. Tournier, V. Cahn et al., Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroid, Virchows Archiv, vol.1821, issue.6, pp.619-651, 2013.
DOI : 10.1016/j.bbalip.2011.05.004

G. Gauchotte, L. Martrille, F. Plénat, and J. Vignaud, The markers of wound vitality in forensic pathology], Ann Pathol. 2013, vol.33, issue.2, pp.93-101

C. Duchêne, A combination of smears and cell block preparations provides high diagnostic accuracy for endobronchial ultrasound-guided transbronchial needle aspiration. Virchows Arch, pp.505-517, 2012.

F. Coste, J. Vignaud, J. Guéant, and L. Peyrin-biroulet, Methyl donor deficiency affects smallintestinal differentiation and barrier function in rats, Br J Nutr Jul, vol.16, pp.1-11, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01704507

G. Gauchotte, C. Vigouroux, F. Rech, S. Battaglia-hsu, M. Soudant et al., Expression of Minichromosome Maintenance MCM6 Protein in Meningiomas is Strongly Correlated With Histologic Grade and Clinical Outcome, The American Journal of Surgical Pathology, vol.36, issue.2, pp.283-91, 2012.
DOI : 10.1097/PAS.0b013e318235ee03

J. Vignaud, Diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal lymph nodes] Ann Pathol, pp.142-51, 2011.

M. Klein, J. Vignaud, and A. Bressenot, BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis, Pathology, vol.43, issue.5, pp.447-52, 2011.

J. Vignaud, Salivary gland anlage tumor: a clinicopathological study of two cases, Fetal Pediatr Pathol, vol.30, issue.2, pp.116-139, 2011.

R. Chetty, S. Serra, G. Gauchotte, B. Märkl, and A. Agaimy, Sclerosing nodular lesions of the gastrointestinal tract containing large numbers of IgG4 plasma cells, Pathology, vol.43, issue.1, 2011.
DOI : 10.1097/PAT.0b013e328340e450

G. Gauchotte and A. Bressenot, Colonic cryptosporidiosis in allograft patients: a rare differential diagnosis of acute graft-versus-host disease, Human Pathology, vol.41, issue.6, pp.918-927, 2010.
DOI : 10.1016/j.humpath.2010.01.017

G. Gauchotte, F. Baylac, M. B. Vignaud, and J. , Medullomyoblastoma: a medulloblastoma with rhabdomyoblastic differentiation] Ann Pathol, pp.135-143, 2010.

A. Moisei, G. Gauchotte, R. Sanou, G. Dautel, J. Vignaud et al., R??ponse du e-quid de d??cembre, Journal de Radiologie, vol.91, issue.1, pp.82-89, 2010.
DOI : 10.1016/S0221-0363(10)70013-5

A. Bressenot, C. Delaunay, G. Gauchotte, A. Oliver, G. Boudrant et al., Composite renal cell carcinoma with clear cell renal cell carcinomatous and carcinoid tumoral elements: a first case report, Journal of Clinical Pathology, vol.63, issue.2, pp.174-180, 2010.
DOI : 10.1136/jcp.2009.070292

A. Bressenot, O. Zimmer, S. Marchal, G. Gauchotte, K. Montagne et al., Detection of apoptosis in vivo: comparison of different methods in histological sections of subcutaneous xenografts of HT29 human colon adenocarcinoma], Ann Pathol, vol.29, issue.5, 2009.

A. Bressenot, N. Marcon, B. Feuillu, G. Gauchotte, and K. Montagne, Primary leiomyosarcoma of the epididymis: a case report with review of the literature], Prog Urol, 2009.

G. Gauchotte, A. Bressenot, T. Serradori, P. Boissel, F. Plénat et al., Reactive nodular fibrous pseudotumor: A first report of gastric localization and clinicopathologic review, Gastroent??rologie Clinique et Biologique, vol.33, issue.12, 2009.
DOI : 10.1016/j.gcb.2009.04.012

E. Gauchotte, G. Gauchotte, M. B. Pruna, L. Koebele, and A. , Une vascularite isol??e du col et de l???isthme ut??rins, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.38, issue.6, pp.521-524, 2009.
DOI : 10.1016/j.jgyn.2009.04.005

G. Gauchotte, M. B. Pinelli, C. Foscolo, S. Vignaud, and J. , [A pigmented tumour of medullary cone], Ann Pathol, vol.29, issue.2, 2009.

G. Gauchotte, S. Tissier, J. Wassel, and D. Régent, Scanner multicoupe en lat??rocubitus avec man??uvre de Valsalva dans l?????tude des hernies de la paroi abdominale, Journal de Radiologie, vol.89, issue.9, pp.1113-1119, 2008.
DOI : 10.1016/S0221-0363(08)73919-2

G. Gauchotte, C. Vigouroux, F. Rech, S. Battaglia-hsu, M. Soudant et al., L'expression de MCM6 dans les méningiomes est fortement corrélée au grade histologique et à l'évolution clinique Journée Claude Huriet de la recherche biomédicale 2012

G. Gauchotte, C. Vigouroux, F. Rech, S. Battaglia-hsu, M. Soudant et al., L'expression de MCM6 dans les méningiomes est fortement corrélée au grade histologique et à l'évolution clinique

S. Hsu, Valeur pronostique de la surexpression de HuR dans les méningiomes et effets sur la prolifération cellulaire et la résistance à l'hypoxie

G. Gauchotte, C. Vigouroux, F. Rech, S. Battaglia-hsu, M. Soudant et al., Expression of mini-chromosome maintenance MCM6 protein in meningiomas is strongly correlated with histological grade and clinical outcome, 2012.